• Je něco špatně v tomto záznamu ?

No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy

P. Baliakas, M. Mattsson, A. Hadzidimitriou, E. Minga, A. Agathangelidis, LA. Sutton, L. Scarfo, Z. Davis, XJ. Yan, K. Plevova, Y. Sandberg, FJ. Vojdeman, T. Tzenou, CC. Chu, S. Veronese, L. Mansouri, KE. Smedby, V. Giudicelli, F. Nguyen-Khac, P....

. 2018 ; 103 (4) : e158-e161. [pub] 20171221

Jazyk angličtina Země Itálie

Typ dokumentu dopisy, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19035464

Grantová podpora
NV15-30015A MZ0 CEP - Centrální evidence projektů

1st Department of Propaedeutic Medicine University of Athens Greece

CEITEC Central European Institute of Technology MasarykBrno Czech Republic

CEITEC Central European Institute of Technology MasarykBrno Czech Republic University Hospital Brno Czech Republic

Department of Haematology Royal Bournemouth Hospital Bournemouth UK

Department of Hemato Oncology Belfast City Hospital Belfast UK

Department of Hematology Rigshospitalet Copenhagen Denmark

Department of Immunology Erasmus MC University Medical Center Rotterdam the Netherlands

Department of Immunology Mayo Clinic Rochester MV USA

Department of Medicine Hematology and Clinical Immunology Branch Padova University School of Medicine Italy Venetian Institute of Molecular Medicine Padova Italy

Department of Medicine Solna Clinical Epidemiology Unit Karolinska Institutet and Hematology Center Karolinska University Hospital Stockholm Sweden

Division of Hematology Department of Medicine Mayo Clinic Rochester MN USA

Hematology Department and HCT Unit G Papanicolaou Hospital Thessaloniki Greece

Hematology Department and University Pierre et Marie Curie Hopital Pitie Salpetriere Paris France

Hematology Department Nikea General Hospital Piraeus Greece

IMGT® the international ImMunoGeneTics information system® Université de Montpellier Laboratoire d'ImmunoGénétique Moléculaire LIGM Institut de Génétique Humaine IGH UPR CNRS 1142 Montpellier France

Immunology Genetics and Pathology Science for Life Laboratory Uppsala University Sweden

Immunology Genetics and Pathology Science for Life Laboratory Uppsala University Sweden Department of Hematology Uppsala University Hospital Sweden

Immunology Genetics and Pathology Science for Life Laboratory Uppsala University Sweden Department of Molecular Medicine and Surgery Karolinska Institutet Stockholm Sweden

Immunology Genetics and Pathology Science for Life Laboratory Uppsala University Sweden Institute of Applied Biosciences Thessaloniki Greece Hematology Department and HCT Unit G Papanicolaou Hospital Thessaloniki Greece

Institute of Applied Biosciences Thessaloniki Greece

Institute of Applied Biosciences Thessaloniki Greece Università Vita Salute San Raffaele Milan Italy Strategic Research Program in CLL Division of Experimental Oncology IRCCS San Raffaele Scientific Institute Milan Italy

Lund University and Hospital Department of Hematology Lund Stem Cell Center Sweden

Molecular Pathology Unit and Haematology Department Niguarda Cancer Center Niguarda Hospital Milan Italy

The Feinstein Institute for Medical Research Northwell Health New York USA

Università Vita Salute San Raffaele Milan Italy Strategic Research Program in CLL Division of Experimental Oncology IRCCS San Raffaele Scientific Institute Milan Italy

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19035464
003      
CZ-PrNML
005      
20231114151956.0
007      
ta
008      
191007s2018 it f 000 0|eng||
009      
AR
024    7_
$a 10.3324/haematol.2017.182634 $2 doi
035    __
$a (PubMed)29269523
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a it
100    1_
$a Baliakas, Panagiotis $u Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden.
245    10
$a No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy / $c P. Baliakas, M. Mattsson, A. Hadzidimitriou, E. Minga, A. Agathangelidis, LA. Sutton, L. Scarfo, Z. Davis, XJ. Yan, K. Plevova, Y. Sandberg, FJ. Vojdeman, T. Tzenou, CC. Chu, S. Veronese, L. Mansouri, KE. Smedby, V. Giudicelli, F. Nguyen-Khac, P. Panagiotidis, G. Juliusson, A. Anagnostopoulos, MP. Lefranc, L. Trentin, M. Catherwood, M. Montillo, CU. Niemann, AW. Langerak, S. Pospisilova, N. Stavroyianni, N. Chiorazzi, D. Oscier, DF. Jelinek, T. Shanafelt, N. Darzentas, C. Belessi, F. Davi, P. Ghia, R. Rosenquist, K. Stamatopoulos,
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a farmakoterapie $x mortalita $7 D004358
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a imunoterapie $x mortalita $7 D007167
650    _2
$a chronická lymfatická leukemie $x farmakoterapie $x mortalita $7 D015451
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a míra přežití $7 D015996
650    _2
$a mladý dospělý $7 D055815
655    _2
$a dopisy $7 D016422
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Mattsson, Mattias $u Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden. Department of Hematology, Uppsala University Hospital, Sweden.
700    1_
$a Hadzidimitriou, Anastasia $u Institute of Applied Biosciences, Thessaloniki, Greece.
700    1_
$a Minga, Eva $u Institute of Applied Biosciences, Thessaloniki, Greece.
700    1_
$a Agathangelidis, Andreas $u Institute of Applied Biosciences, Thessaloniki, Greece. Università Vita-Salute San Raffaele, Milan, Italy. Strategic Research Program in CLL, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
700    1_
$a Sutton, Lesley-Ann $u Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden.
700    1_
$a Scarfo, Lydia $u Università Vita-Salute San Raffaele, Milan, Italy. Strategic Research Program in CLL, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
700    1_
$a Davis, Zadie $u Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK.
700    1_
$a Yan, Xiao-Jie $u The Feinstein Institute for Medical Research, Northwell Health, New York, USA.
700    1_
$a Plevova, Karla $u CEITEC-Central European Institute of Technology, MasarykBrno, Czech Republic. University Hospital Brno, Czech Republic.
700    1_
$a Sandberg, Yorick $u Department of Immunology, Erasmus MC, University Medical Center Rotterdam, the Netherlands.
700    1_
$a Vojdeman, Fie J $u Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
700    1_
$a Tzenou, Tatiana $u First Department of Propaedeutic Medicine, University of Athens, Greece.
700    1_
$a Chu, Charles C $u The Feinstein Institute for Medical Research, Northwell Health, New York, USA.
700    1_
$a Veronese, Silvio $u Molecular Pathology Unit and Haematology Department, Niguarda Cancer Center, Niguarda Hospital, Milan, Italy.
700    1_
$a Mansouri, Larry $u Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden.
700    1_
$a Smedby, Karin E $u Department of Medicine Solna, Clinical Epidemiology Unit, Karolinska Institutet, and Hematology Center, Karolinska University Hospital, Stockholm, Sweden.
700    1_
$a Giudicelli, Véronique $u IMGT®, the international ImMunoGeneTics information system®, Université de Montpellier, Laboratoire d'ImmunoGénétique Moléculaire LIGM, Institut de Génétique Humaine IGH, UPR CNRS 1142, Montpellier, France.
700    1_
$a Nguyen-Khac, Florence $u Hematology Department and University Pierre et Marie Curie, Hopital Pitie-Salpetriere, Paris, France.
700    1_
$a Panagiotidis, Panagiotis $u First Department of Propaedeutic Medicine, University of Athens, Greece.
700    1_
$a Juliusson, Gunnar $u Lund University and Hospital Department of Hematology, Lund Stem Cell Center, Sweden.
700    1_
$a Anagnostopoulos, Achilles $u Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
700    1_
$a Lefranc, Marie-Paule $u IMGT®, the international ImMunoGeneTics information system®, Université de Montpellier, Laboratoire d'ImmunoGénétique Moléculaire LIGM, Institut de Génétique Humaine IGH, UPR CNRS 1142, Montpellier, France.
700    1_
$a Trentin, Livio $u Department of Medicine, Hematology and Clinical Immunology Branch, Padova University School of Medicine, Italy. Venetian Institute of Molecular Medicine, Padova, Italy.
700    1_
$a Catherwood, Mark $u Department of Hemato-Oncology, Belfast City Hospital, Belfast, UK.
700    1_
$a Montillo, Marco $u Molecular Pathology Unit and Haematology Department, Niguarda Cancer Center, Niguarda Hospital, Milan, Italy.
700    1_
$a Niemann, Carsten U $u Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
700    1_
$a Langerak, A. W., $u Department of Immunology, Erasmus MC, University Medical Center Rotterdam, the Netherlands. $d 1967- $7 xx0310084
700    1_
$a Pospisilova, Sarka $u CEITEC-Central European Institute of Technology, MasarykBrno, Czech Republic. University Hospital Brno, Czech Republic.
700    1_
$a Stavroyianni, Niki $u Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
700    1_
$a Chiorazzi, Nicholas $u The Feinstein Institute for Medical Research, Northwell Health, New York, USA.
700    1_
$a Oscier, David $u Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK.
700    1_
$a Jelinek, Diane F $u Department of Immunology, Mayo Clinic, Rochester, MV, USA.
700    1_
$a Shanafelt, Tait $u Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
700    1_
$a Darzentas, Nikos $u CEITEC-Central European Institute of Technology, MasarykBrno, Czech Republic.
700    1_
$a Belessi, Chrysoula $u Hematology Department, Nikea General Hospital, Piraeus, Greece.
700    1_
$a Davi, Frederic $u Hematology Department and University Pierre et Marie Curie, Hopital Pitie-Salpetriere, Paris, France.
700    1_
$a Ghia, Paolo $u Università Vita-Salute San Raffaele, Milan, Italy. Strategic Research Program in CLL, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
700    1_
$a Rosenquist, Richard $u Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden. Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
700    1_
$a Stamatopoulos, Kostas $u Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden kostas.stamatopoulos@gmail.com. Institute of Applied Biosciences, Thessaloniki, Greece. Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
773    0_
$w MED00001963 $t Haematologica $x 1592-8721 $g Roč. 103, č. 4 (2018), s. e158-e161
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29269523 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20191007 $b ABA008
991    __
$a 20231114151952 $b ABA008
999    __
$a ok $b bmc $g 1452124 $s 1074014
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 103 $c 4 $d e158-e161 $e 20171221 $i 1592-8721 $m Haematologica $n Haematologica $x MED00001963
GRA    __
$a NV15-30015A $p MZ0
LZP    __
$a Pubmed-20191007

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...